{"title":"Prognostic Impact of Metastasis Timing in Metastatic Gastrointestinal Stromal Tumors: A Multicenter Retrospective Cohort Study.","authors":"Kunihiko Kawai, Tsuyoshi Takahashi, Ryugo Teranishi, Shinsuke Sato, Yukinori Kurokawa, Toshirou Nishida, Seiichi Hirota, Jyunya Fujita, Yuichiro Doki, Toshimasa Tsujinaka","doi":"10.1002/ags3.70245","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gastrointestinal stromal tumors (GISTs) commonly metastasize to the liver and peritoneum. Metastases may be detected synchronously at the time of initial diagnosis or develop metachronously after curative-intent resection. Nonetheless, the prognostic significance of metastasis timing in advanced GIST remains unclear.</p><p><strong>Methods: </strong>We retrospectively analyzed 147 patients with metastatic GIST treated at multiple institutions between 2003 and 2012. The patients were categorized into synchronous (<i>n</i> = 51) and metachronous (<i>n</i> = 96) groups. Clinicopathological characteristics and overall survival (OS) were compared using Kaplan-Meier analysis and Cox proportional hazards models. Among patients with metachronous disease, the outcomes were further evaluated according to the recurrence interval.</p><p><strong>Results: </strong>The median OS was significantly shorter in the synchronous group (6.7 years) than in the metachronous group (12.8 years; <i>p</i> = 0.001). Metastasis timing remained an independent prognostic factor in multivariable analysis (hazard ratio 2.36, 95% confidence interval 1.39-4.00; <i>p</i> = 0.001). Among patients with metachronous metastasis, early recurrence within 2 years after surgery was associated with significantly inferior survival compared to late recurrence.</p><p><strong>Conclusion: </strong>Metastasis timing was associated with survival in patients with metastatic GIST. Both synchronous presentation and early metachronous recurrence were associated with poorer outcomes.</p>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":" ","pages":"1663-1672"},"PeriodicalIF":3.2000,"publicationDate":"2026-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13394631/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Gastroenterological Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ags3.70245","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Gastrointestinal stromal tumors (GISTs) commonly metastasize to the liver and peritoneum. Metastases may be detected synchronously at the time of initial diagnosis or develop metachronously after curative-intent resection. Nonetheless, the prognostic significance of metastasis timing in advanced GIST remains unclear.
Methods: We retrospectively analyzed 147 patients with metastatic GIST treated at multiple institutions between 2003 and 2012. The patients were categorized into synchronous (n = 51) and metachronous (n = 96) groups. Clinicopathological characteristics and overall survival (OS) were compared using Kaplan-Meier analysis and Cox proportional hazards models. Among patients with metachronous disease, the outcomes were further evaluated according to the recurrence interval.
Results: The median OS was significantly shorter in the synchronous group (6.7 years) than in the metachronous group (12.8 years; p = 0.001). Metastasis timing remained an independent prognostic factor in multivariable analysis (hazard ratio 2.36, 95% confidence interval 1.39-4.00; p = 0.001). Among patients with metachronous metastasis, early recurrence within 2 years after surgery was associated with significantly inferior survival compared to late recurrence.
Conclusion: Metastasis timing was associated with survival in patients with metastatic GIST. Both synchronous presentation and early metachronous recurrence were associated with poorer outcomes.